<unk>  neither inhibits nor stimulates cytochrome P450 family (CYP) of oxidizing enzymes in human, thus would not cause clinically significant interactions with other drugs, which are metabolized by CYPs. However, the risk or severity of adverse effects can be increased when<unk>  is combined with other drugs, but this is not related to substrates, inducers and inhibitors of CYPs.
Sulpiride
Buspirone
Dapoxetine
Bupropion
Vortioxetine
Electroconvulsive therapy
Atomoxetine
Edivoxetine